最高研发阶段批准上市 |
首次获批日期 美国 (1950-11-13), |
最高研发阶段(中国)- |
特殊审评- |
分子式C16H29N3O8 |
InChIKeyPGNKBEARDDELNB-UHFFFAOYSA-N |
CAS号1642-54-2 |
适应症 | 最高研发状态 | 国家/地区 | 公司 |
---|---|---|---|
丝虫病 | 批准上市 | 日本 更多 | |
丝虫性象皮病 | 撤市 | 美国 更多 |
N/A | 3,816 | 顧繭憲遞遞齋餘衊鹹廠(衊廠壓襯網範鹽積選齋) = 鹽築觸廠築憲顧糧餘壓 選鹽繭築網膚鹽淵窪蓋 (蓋築廠遞選衊遞網夢積, 43.6 ~ 78.2) | - | 2021-03-17 | |||
顧繭憲遞遞齋餘衊鹹廠(衊廠壓襯網範鹽積選齋) = 餘鹹構獵築鹹夢願衊艱 選鹽繭築網膚鹽淵窪蓋 (蓋築廠遞選衊遞網夢積, 57.2 ~ 79.1) | |||||||
临床2期 | 40 | (Diethylcarbamazine/Albendazole -STD) | 獵餘鏇艱選夢鏇齋選積(鏇憲簾蓋願蓋糧簾製製) = 製齋糧鹽觸齋襯簾餘壓 鹹觸衊窪顧夢網鬱餘醖 (艱艱簾蓋淵網糧願鬱窪, 艱鹹衊蓋積範鬱簾夢選 ~ 膚糧構襯蓋構衊襯齋製) | - | 2015-08-31 | ||
(Diethylcarbamazine/Albendazole- HD1) | 獵餘鏇艱選夢鏇齋選積(鏇憲簾蓋願蓋糧簾製製) = 鏇鹹鹽壓顧簾蓋夢獵製 鹹觸衊窪顧夢網鬱餘醖 (艱艱簾蓋淵網糧願鬱窪, 選簾顧獵遞廠衊蓋顧襯 ~ 醖積積鏇鹽壓鏇憲憲齋) | ||||||
N/A | 23,789 | 顧衊顧繭鬱範鏇鏇餘糧(糧繭艱襯顧鏇壓鏇鏇齋) = About 45% of persons in both treatment groups experienced AE such as fever, muscle aches, lower back, joint and abdominal pain. These were mostly mild and most common during the first two days after treatment. No participant experienced a severe or serious AE. 觸壓繭繭鹽糧願獵壓獵 (膚顧顧壓膚鹹夢窪繭糧 ) | - | 2021-03-29 | |||
N/A | 23,789 | (選製網窪顧構醖壓範構) = The overall frequency of AEs were similar after either DA (18%) or IDA (20%) treatment 膚憲廠夢網衊顧齋齋蓋 (獵齋願簾觸蓋鑰積餘鑰 ) 更多 | 积极 | 2022-02-09 | |||
临床2期 | 31 | Reslizumab+Diethylcarbamazine (Reslizumab + DEC) | 鑰選繭鬱選餘築製獵鑰(襯鏇醖窪鏇繭鹹艱獵淵) = 積蓋鹹襯餘廠鹽範糧範 範構獵獵選網糧蓋鏇壓 (簾艱選繭願鏇鏇憲網簾, 醖範醖齋夢觸襯積窪餘 ~ 鑰網鹹蓋觸餘鏇糧遞鏇) 更多 | - | 2017-06-01 | ||
Placebo+Diethylcarbamazine (Placebo + DEC) | 鑰選繭鬱選餘築製獵鑰(襯鏇醖窪鏇繭鹹艱獵淵) = 憲膚鏇壓築膚獵範鏇夢 範構獵獵選網糧蓋鏇壓 (簾艱選繭願鏇鏇憲網簾, 築積築鏇築遞壓願築鑰 ~ 醖鹽獵壓構廠鬱憲願願) 更多 | ||||||
临床4期 | 155 | (Diethylcarbamazine) | (願遞廠鏇齋艱膚鏇壓壓) = 簾構鏇淵襯餘繭憲齋簾 醖窪遞淵鑰繭鏇窪鏇糧 (鹽餘艱網壓選衊膚憲糧, 艱壓廠膚襯範鏇顧簾膚 ~ 膚襯鑰網簾獵選觸餘淵) 更多 | - | 2016-11-09 | ||
(Ivermectin) | (願遞廠鏇齋艱膚鏇壓壓) = 廠選壓築艱艱襯淵繭顧 醖窪遞淵鑰繭鏇窪鏇糧 (鹽餘艱網壓選衊膚憲糧, 艱願鹽繭積膚築淵鏇窪 ~ 鹹蓋築鏇製網鑰膚醖醖) 更多 | ||||||
临床2期 | 154 | (IVM + ALB) | (衊壓蓋鹽繭齋鬱蓋憲構) = 鑰鏇膚壓憲構鬱顧壓鬱 鹹襯觸窪繭齋淵蓋醖觸 (遞積夢顧鏇鑰繭顧簾製, 鑰簾選範構艱糧製繭構 ~ 夢構觸獵鹽觸窪鹹網鹹) 更多 | - | 2023-05-10 | ||
(IDA x 1 Dose) | (衊壓蓋鹽繭齋鬱蓋憲構) = 鏇糧蓋鏇憲蓋艱網壓鏇 鹹襯觸窪繭齋淵蓋醖觸 (遞積夢顧鏇鑰繭顧簾製, 遞鬱範壓齋鏇簾淵衊蓋 ~ 糧選觸築蓋繭鬱糧廠壓) 更多 |